Surgery as a viable alternative first-line treatment for prolactinoma patients. A systematic review and meta-analysis.

CONCLUSIONS: In the majority of prolactinoma patients disease remission can be achieved through surgery, with low risks of long-term surgical complications, and disease remission is less often achieved with dopamine agonists.
PMID: 31665485 [PubMed - as supplied by publisher]

Source: The Journal of Clinical Endocrinology and Metabolism - October 28, 2019 Category: Endocrinology Authors: Zamanipoor Najafabadi AH, Zandbergen IM, de Vries F, Broersen LHA, van den Akker-van Marle ME, Pereira AM, Peul WC, Dekkers OM, van Furth WR, Biermasz NR Tags: J Clin Endocrinol Metab Source Type: research